X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
WYETH LTD Fact Sheet, WYETH LTD Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD Fact Sheet   (WYLD)

Here is the latest financial fact sheet of WYETH LTD. For more details, see the WYETH LTD quarterly results and WYETH LTD share price and chart. For a sector overview, read our pharmaceuticals sector report.

WYETH LTD Price History

Price Rs 1,334.6
Mkt Cap Rs m 30,322
Vol '000 6.2
P/E X 27.7
P/CF X 22.8
EPS (TTM) Rs 48.1
% ch % -2.3
No. of shares m 22.72
% ch week % 7.5
% ch 1-mth % 18.6
% ch 12-mth % 69.6
52 week H/L Rs 1,409.0/688.3
(As on Dec 9, 2014 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

WYETH LTD Financials

No. of Mths
Year Ending
12
Mar-09
8
Nov-09
16
Mar-11
12
Mar-12
12
Mar-13
5-Yr Chart
Click to enlarge
WYETH LTD EQUITY SHARE DATA
High Rs5097739001,0751,044 
Low Rs348414691794818 
Sales per share (Unadj.) Rs168.4126.0282.2259.0298.6 
Earnings per share (Unadj.) Rs43.926.072.863.757.2 
Diluted earnings per shareRs43.926.072.863.757.2 
Cash flow per share (Unadj.) Rs46.928.976.766.358.4 
Dividends per share (Unadj.) Rs32.5020.0022.0018.0017.00 
Adj. dividends per shareRs32.5020.0022.0018.0017.00 
Dividend yield (eoy) %7.63.42.81.91.8 
Book value per share (Unadj.) Rs119.6122.1169.4212.1249.5 
Adj. book value per shareRs119.6122.1169.4212.1249.5 
Shares outstanding (eoy) m22.7222.7222.7222.7222.72 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x2.54.72.83.63.1 
Avg P/E ratio x9.822.910.914.716.3 
P/CF ratio (eoy) x9.120.510.414.115.9 
Price / Book Value ratio x3.64.94.74.43.7 
Dividend payout %74.177.030.228.329.7 
Avg Mkt Cap Rs m9,73613,48418,07421,23221,157 
No. of employees `0000.80.80.50.50.5 
Total wages/salary Rs m428347513377400 
Avg. sales/employee Rs Th4,638.23,522.312,524.411,339.713,787.4 
Avg. wages/employee Rs Th519.2426.91,001.8727.2813.0 
Avg. net profit/employee Rs Th1,208.2725.73,228.32,788.12,643.3 
WYETH LTD INCOME DATA
Net Sales Rs m3,8272,8646,4135,8856,783 
Other income Rs m215100199340353 
Total revenues Rs m4,0422,9646,6126,2257,136 
Gross profit Rs m1,2867872,2831,7781,617 
Depreciation Rs m6968905927 
Interest Rs m431356 
Profit before tax Rs m1,4298172,3802,0541,938 
Minority Interest Rs m00000 
Prior Period Items Rs m01000 
Extraordinary Inc (Exp) Rs m-50-23-5-5 
Tax Rs m427229704602632 
Profit after tax Rs m9975901,6531,4471,301 
Gross profit margin %33.627.535.630.223.8 
Effective tax rate %29.928.029.629.332.6 
Net profit margin %26.020.625.824.619.2 
WYETH LTD BALANCE SHEET DATA
Current assets Rs m3,8783,6454,1325,6716,984 
Current liabilities Rs m1,5801,2419191,4292,056 
Net working cap to sales %60.084.050.172.172.6 
Current ratio x2.52.94.54.03.4 
Inventory Days Days5376427499 
Debtors Days Days2325193424 
Net fixed assets Rs m389326271257244 
Share capital Rs m227227227227227 
"Free" reserves Rs m2,4902,5483,6214,5925,441 
Net worth Rs m2,7172,7753,8484,8195,668 
Long term debt Rs m2525252525 
Total assets Rs m4,3224,0414,9946,4937,901 
Interest coverage x358.2292.9191.4428.9353.3 
Debt to equity ratio x00000 
Sales to assets ratio x0.90.71.30.90.9 
Return on assets %23.214.733.322.416.5 
Return on equity %36.721.343.030.022.9 
Return on capital %52.129.361.242.434.0 
Exports to sales %0.20.20.40.10.2 
Imports to sales %21.121.922.728.436.3 
Exports (fob) Rs m8628815 
Imports (cif) Rs m8096281,4561,6742,465 
Fx inflow Rs m96291115 
Fx outflow Rs m1,2031,0511,9111,7822,677 
Net fx Rs m-1,194-1,044-1,882-1,772-2,662 
WYETH LTD CASH FLOW
From Operations Rs m 602 578 1,510 764 923 
From Investments Rs m 142 101 115 313 317 
From Financial Activity Rs m -801 -863 -936 -188 -481 
Net Cashflow Rs m -57 -184 689 889 759 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

WYETH LTD Raw Materials Data

ITEM Rs m % To R.M.C. % To SALES
Levonogestrel/nogestrel 37.0 4.5 0.5
Others 240.6 29.5 3.4
Prednisolone 538.4 66.0 7.7

Share Holding

Indian Promoters 0.0%
Foreign collaborators 51.1%
Indian inst/Mut Fund 11.3%
FIIs 7.2%
ADR/GDR 0.0%
Free float 30.4%
Shareholders 21,978
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Level 6, Platina, Plot No. C-59, G Block, BKC, Bandra (E), Mumbai - 400 098
E-MAIL thakorn@wyeth.com WEB www.wyethindia.com
TELEPHONE (022) 2657 4000 FAX (022) 2657 4100
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR B. S. R & Assoc.
CHM: Pradip Shah COMP SEC: Neema Thakore YEAR OF INC: 1947 BSE CODE: 500095 FV (Rs): 10 DIV YIELD (%): 1.3

More Pharmaceuticals Company Fact Sheets:   IPCA LABS  GLENMARK PHARMA  CADILA HEALTHCARE  NOVARTIS  FULFORD INDIA  

Compare WYETH LTD With:   IPCA LABS  GLENMARK PHARMA  CADILA HEALTHCARE  NOVARTIS  FULFORD INDIA  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WYETH LTD

WYETH LTD - MYLAN COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS